Cargando…
Sublingual immunization with recombinant adenovirus encoding SARS-CoV spike protein induces systemic and mucosal immunity without redirection of the virus to the brain
BACKGROUND: Sublingual (s.l.) administration of soluble protein antigens, inactivated viruses, or virus-like particles has been shown to induce broad immune responses in mucosal and extra-mucosal tissues. Recombinant replication-defective adenovirus vectors (rADVs) infect mucosa surface and therefor...
Autores principales: | Shim, Byoung-Shik, Stadler, Konrad, Nguyen, Huan Huu, Yun, Cheol-Heui, Kim, Dong Wook, Chang, Jun, Czerkinsky, Cecil, Song, Man Ki |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3489719/ https://www.ncbi.nlm.nih.gov/pubmed/22995185 http://dx.doi.org/10.1186/1743-422X-9-215 |
Ejemplares similares
-
Sublingual Delivery of Vaccines for the Induction of Mucosal Immunity
por: Shim, Byoung-Shik, et al.
Publicado: (2013) -
Sublingual Immunization with M2-Based Vaccine Induces Broad Protective Immunity against Influenza
por: Shim, Byoung-Shik, et al.
Publicado: (2011) -
Intranasal immunization with plasmid DNA encoding spike protein of SARS-coronavirus/polyethylenimine nanoparticles elicits antigen-specific humoral and cellular immune responses
por: Shim, Byoung-Shik, et al.
Publicado: (2010) -
Buccal and sublingual vaccine delivery
por: Kraan, Heleen, et al.
Publicado: (2014) -
Mucosal Immunity and Sublingual Immunotherapy in Respiratory Disorders
por: Bahceciler, Nerin N.
Publicado: (2012)